Literature DB >> 23394494

Tourniquet-induced ischemia-reperfusion injuries during extremity surgery at children's age: impact of anesthetic chemical structure.

Ivana Budic1, Dusica Pavlovic, Dusanka Kitic, Gordana Kocic, Tatjana Cvetkovic, Dusica Simic, Tatjana Jevtovic-Stoimenov.   

Abstract

OBJECTIVES: The aim of this study was to determine the relationship between the antioxidant profile of anesthetics and its relation to total antioxidant capacity (TAC) of plasma in children who underwent tourniquet-induced ischemia-reperfusion (IR) injury during extremity operations.
METHODS: Children were randomized into three groups: general inhalational anesthesia with sevoflurane (group S), total intravenous anesthesia (TIVA) with propofol (group T), and regional anesthesia (group R). Venous blood samples were obtained before peripheral nerve block and induction of general anesthesia (baseline), 1 minute before tourniquet release (BTR), and 5 and 20 minutes after tourniquet release (ATR). Plasma TAC as well as antioxidant potential of propofol, thiopental, and bupivacaine were measured using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay.
RESULTS: Plasma TAC in group T was increased significantly at 20 minutes ATR in comparison with basal and BTR values, and also was significantly higher in comparison with plasma TAC in groups S and R measured at the same time point. The radical scavenging activity of anesthetics in vitro indicated that only propofol possessed a significant antioxidative activity in the reaction with DPPH radical in comparison with thiopental and bupivacaine. DISCUSSION: These data confirm that TIVA with propofol attenuates oxidative stress related to tourniquet-induced ischaemia-reperfusion injury in children.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23394494      PMCID: PMC6837468          DOI: 10.1179/1351000212Y.0000000037

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  35 in total

1.  Antioxidant property of Propofol in the ischemic and reperfused human skeletal muscle.

Authors:  G G Corbucci; A Marchi; C Velluti; C Chelo; E Grella; B Lettieri
Journal:  Minerva Anestesiol       Date:  2002 Jan-Feb       Impact factor: 3.051

2.  Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.

Authors:  Anna Onishi; Masami Miyamae; Kazuhiro Kaneda; Junichiro Kotani; Vincent M Figueredo
Journal:  Eur J Pharmacol       Date:  2011-12-07       Impact factor: 4.432

3.  Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma.

Authors:  A Janaszewska; G Bartosz
Journal:  Scand J Clin Lab Invest       Date:  2002       Impact factor: 1.713

4.  Effect of propofol and thiopentone on free radical mediated oxidative stress of the erythrocyte.

Authors:  P G Murphy; M J Davies; M O Columb; N Stratford
Journal:  Br J Anaesth       Date:  1996-04       Impact factor: 9.166

5.  Thiopental improves renal ischemia-reperfusion injury.

Authors:  Zafer Dogan; Mehmet Fatih Yuzbasioglu; Ergul Belge Kurutas; Huseyin Yildiz; Ismail Coskuner; Nimet Senoglu; Hafize Oksuz; Ertan Bülbüloglu
Journal:  Ren Fail       Date:  2010-01       Impact factor: 2.606

6.  Choice of anesthetic combination determines Ca2+ leak after ischemia-reperfusion injury in the working rat heart: favorable versus adverse combinations.

Authors:  Michael Zaugg; Lianguo Wang; Liyan Zhang; Phing-How Lou; Eliana Lucchinetti; Alexander S Clanachan
Journal:  Anesthesiology       Date:  2012-03       Impact factor: 7.892

7.  Ischemia-reperfusion injury in skeletal muscle: comparison of the effects of subanesthetic doses of ketamine, propofol, and etomidate.

Authors:  Yusuf Ergün; Hafize Oksüz; Yalcin Atli; Metin Kilinç; Sacide Darendeli
Journal:  J Surg Res       Date:  2008-08-27       Impact factor: 2.192

8.  Relative antioxidant capacities of propofol and its main metabolites.

Authors:  Sandrine Boisset; Jean-Paul Steghens; Patrick Favetta; Raphaël Terreux; Jérôme Guitton
Journal:  Arch Toxicol       Date:  2004-07-10       Impact factor: 5.153

9.  Comparative study on determination of antioxidant and membrane activities of propofol and its related compounds.

Authors:  Hironori Tsuchiya; Takahiro Ueno; Toshiyuki Tanaka; Nobuyasu Matsuura; Maki Mizogami
Journal:  Eur J Pharm Sci       Date:  2009-11-06       Impact factor: 4.384

10.  Time course and attenuation of ischaemia-reperfusion induced oxidative injury by propofol in human renal transplantation.

Authors:  Samar Basu; Isabelle Meisert; Elisabeth Eggensperger; Elisabeth Krieger; Claus G Krenn
Journal:  Redox Rep       Date:  2007       Impact factor: 4.412

View more
  3 in total

1.  Influence of propofol intravenous anesthesia on hemorheology, haemodynamics and immune function of colorectal carcinoma patients undergoing radical resection.

Authors:  Jianmin Yu; Mingfen Han; Jun Geng
Journal:  Pak J Med Sci       Date:  2019       Impact factor: 1.088

Review 2.  Clinical Importance of Potential Genetic Determinants Affecting Propofol Pharmacokinetics and Pharmacodynamics.

Authors:  Ivana Budic; Tatjana Jevtovic Stoimenov; Dimitrije Pavlovic; Vesna Marjanovic; Ivona Djordjevic; Marija Stevic; Dusica Simic
Journal:  Front Med (Lausanne)       Date:  2022-02-28

3.  Reperfusion Interval as a Prevention of Lung Injury Due to Limb Ischemia-Reperfusion After Application of Tourniquet in Murine Experimental Study.

Authors:  Thomas Erwin Christian Junus Huwae; Agung Riyanto Budi Santoso; Wongso Kesuma; Hidayat Sujuti; Retty Ratnawati; William Putera Sukmajaya; Mohammad Hidayat
Journal:  Indian J Orthop       Date:  2020-04-07       Impact factor: 1.251

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.